SEEG

NeuroXess Attends WAIC with its First Medical-Grade BCI Product Pipeline

Retrieved on: 
Thursday, September 8, 2022
Software, Safety, Interface (computing), List of MDPI academic journals, Research, Convention center, View, WAIC, Solution, Exhibition, Severe cognitive impairment, BCI, EEG, Electrocorticography, Electrode, Multimedia, Conference, Compliance, SEEG, LFP, Acquisition, ALS, Medical device, Medical imaging

NeuroXess founder and CEO Peng Lei said that the new offerings are, for the most part, targeted to two markets.

Key Points: 
  • NeuroXess founder and CEO Peng Lei said that the new offerings are, for the most part, targeted to two markets.
  • The compact-sized NeuroInterface is an integrated cranial parietal semi-implantable BCI designed based on medical-grade implant standards.
  • The BCI can support up to 256 channels, double that of similar applications which are limited to 128 channels.
  • MindExplorer is NeuroXess' software and algorithm cloud platform, which builds a digital brain bank through the information stored in the cloud to enable continuous product iteration.

NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

Retrieved on: 
Thursday, August 11, 2022
SEEG, FDA, U.S. Securities and Exchange Commission, EEG, CEO, Forward-looking statement, GLOBE, Population, Failure, HCPS, Growth, SEC, Brain, Cognition, Creativity, Anticonvulsant, Annual report, Analysis, Physician, Health, Autism, Patient, Quality of life, Responsive neurostimulation device, Epilepsy, Multiple sclerosis, Education, Seizure, Lists of diseases, Partnership, Cerebral palsy, Financial condition report, Electrode, Insurance, Neurosurgery, Result, Conditional sentence, Pharmaceutical industry, Medical device

(Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that the company has entered into a commercialization agreement with DIXI Medical USA (DIXI).

Key Points: 
  • (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that the company has entered into a commercialization agreement with DIXI Medical USA (DIXI).
  • For these support services, DIXI will receive an upfront payment along with two additional payments in 2023 and 2024.
  • SEEG electrodes are used in the epilepsy monitoring units of comprehensive epilepsy centers to determine where epileptic seizures originate.
  • We are pleased to entrust DIXI electrodes in the U.S. to the strong and competent team at NeuroPace.

Globus Medical Announces First ExcelsiusGPS® Cranial Surgery

Retrieved on: 
Monday, September 27, 2021
Disclosure, Attention, Annual report, MRI, Efficiency, SEEG, Risk, Security (finance), Pandemic, U.S. Securities and Exchange Commission, Surgeon, Patient, Lists of diseases, Form 10-K, Growth, COVID-19, DBS, Barrow Neurological Institute, Forward-looking statement, Deep brain stimulation, NYSE, Time, GLOBE, Risk management

AUDUBON, Pa., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc.(NYSE: GMED), a leading musculoskeletal solutions company, today announced the first surgery performed with the ExcelsiusGPS Cranial Solutions for robot-assisted navigated Deep Brain Stimulation (DBS).

Key Points: 
  • AUDUBON, Pa., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc.(NYSE: GMED), a leading musculoskeletal solutions company, today announced the first surgery performed with the ExcelsiusGPS Cranial Solutions for robot-assisted navigated Deep Brain Stimulation (DBS).
  • Dr. Ponce will continue to advance his practice to incorporate ExcelsiusGPS for stereotactic cranial procedures.
  • ExcelsiusGPS Cranial Solutions combines streamlined MRI preoperative planning with fully integrated robotic trajectory alignment for a broad spectrum of cranial stereotactic procedures including SEEG, DBS, biopsies, and shunts.
  • With the only Fluoroscopy-to-CT registration modality on the market, ExcelsiusGPS Cranial Solutions offers surgeons the ability to efficiently register the bony anatomy.

Feinstein Institutes’ Bioelectronic Team Decodes Deep Brain Signals Related to Touch and Movement

Retrieved on: 
Tuesday, August 17, 2021
Diabetes, University, Pharmaceutical, Surgery, Physical Therapy, Education, Oncology, Mental Health, Medical Devices, Hospitals, Clinical Trials, Biotechnology, Science, Other Science, Research, Health, Injury, Mark (given name), Baylor College of Medicine, Medicine, Institute, Cancer, Feinstein, Feinstein Institute for Medical Research, Movement, Molecular medicine, Diabetes, Science, Research, Biomedical engineering, Credit, BCI, Paralysis, Mental health, Pulmonary hypertension, Multimedia, Â, Sensation, Risk, Arthritis, CEO, LinkedIn, Electrode, Genetics, Finger, Autoimmunity, SEEG, Brain, Northwell Health, Medical research, Inflammatory bowel disease, White matter, Washington University in St. Louis, Pharmaceutical industry, Medical device, Medical imaging

Tapping deep within the brain, a team of researchers from the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research has deciphered signals related to movement and touch.

Key Points: 
  • Tapping deep within the brain, a team of researchers from the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research has deciphered signals related to movement and touch.
  • View the full release here: https://www.businesswire.com/news/home/20210817005645/en/
    Chad Bouton, professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes.
  • (Credit: The Feinstein Institutes for Medical Research)
    This first demonstration of decoding sulcal and subcortical activity will help researchers better understand how the brain processes tactile stimuli and manages hand motions.
  • By observing these signals hidden deep within the brain, we are one step closer to restoring that sensation through stimulation and advances in the field of bioelectronic medicine.